Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 158

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Management of Pancreatic Endocrine Tumors in Multiple Endocrine Neoplasia Type 1

Kouvaraki, Maria A., Shapiro, Suzanne E., Cote, Gilbert J., Lee, Jeffrey E., Yao, James C., Waguespack, Steven G., Gagel, Robert F., Evans, Douglas B., Perrier, Nancy D. · 2006 · World Journal of Surgery

Abstract

Introduction: Pancreatic endocrine tumors (PETs) occur in at least 50% of patients with multiple endocrine neoplasia type 1 (MEN1) and are the leading cause of disease‐specific mortality. However, the timing and extent of surgery for MEN1‐related PETs is controversial owing to the indolent tumor growth seen in most patients and the desire to avoid complications associated with insulin dependence. To help resolve this controversy, we retrospectively analyzed the clinical characteristics, surgical treatment, and clinical outcome of patients with MEN1‐related PETs. Methods: All patients had histologic or radiographic confirmation of a PET in the setting of MEN1. Disease progression was defined radiographically as the development of new pancreatic tumors or distant metastases. Progression‐free survival (PFS) and overall survival (OS) were used as the endpoints of this analysis. Results: We identified 98 patients with MEN1, 55 (56%) of whom had PETs, including 27 women and 28 men with a median age of 37 years (range 8–69 years) at the time of diagnosis. Functioning PETs were present in 35 (64%) of 55 patients, and nonfunctioning tumors were present in 20 (36%). Pancreatic surgery was performed in 38 (69%) of the 55 patients; and the first operation included enucleation (n = 4), total pancreatectomy (n = 3), Whipple procedure (n = 4), and distal pancreatectomy (n = 27). The median size of the resected tumors was 2.8 cm (range 0.6–11.0 cm). Recurrent disease developed in the residual pancreas in 7 (20%) of 35 at‐risk patients a median of 7.8 years after the first operation, and distant metastases occurred in 5 (14 %) of 36 surgically treated patients without distant metastasis (2 patients had distant metastases when surgery on the primary tumor was performed) at a median of 2.7 years following surgery. At last follow‐up, 16 (29%) of 55 patients with PETs had died, 12 (22%) were alive with disease, 26 (47%) were alive without evidence of disease, and 1 (2%) was lost to follow‐up. The median OS was 19.5 years (range 13–26 years) and was significantly longer for patients who had functioning PETs versus those with nonfunctioning tumors (P= 0.0007), for patients who underwent surgical resection of their PETs versus those who did not (P= 0.0043), and for patients with localized versus metastatic PETs at the time of diagnosis (P< 0.0001). Multivariate analysis revealed that younger age, hormonal function, and PET resection were independently associated with longer OS. Conclusions: Our data suggest that early diagnosis and surgical excision of MEN1‐related PETs improves survival. However, translating these data into a surveillance strategy for the early detection of PETs is complex owing to the potential morbidity of pancreatic resection and the risk of long‐term insulin dependence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00268-006-0360-y

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 158

Metadata

Authors
Kouvaraki, M. A., Shapiro, S. E., Cote, G. J., Lee, J. E., Yao, J. C., Waguespack, S. G., Gagel, R. F., Evans, D. B., & Perrier, N. D.
Venue
World Journal of Surgery
Publisher
Wiley
Published
2006-04-17
Volume
30
Issue
5
Pages
643-653
ISSN
  • 0364-2313 (ISSN-L)
  • 1432-2323
OpenAlex
W2134895907
Cited by
158
References
1
FWCI
6.64
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Management of Pancreatic Endocrine Tumors in Multiple Endocrine Neoplasia Type 1. https://app.cochat.ai/papers/10.1007/s00268-006-0360-y
The paper
Kouvaraki, M. A., Shapiro, S. E., Cote, G. J., Lee, J. E., Yao, J. C., Waguespack, S. G., Gagel, R. F., Evans, D. B., & Perrier, N. D. (2006). Management of Pancreatic Endocrine Tumors in Multiple Endocrine Neoplasia Type 1. World Journal of Surgery. https://doi.org/10.1007/s00268-006-0360-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.